Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2018 Q1- Text added to 2018 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
billable, chemotherapy, gathering, GLPG, grantor, Harmonisation, intermediate, interval, luspatercept, margin, mentioned, month, Nonemployee, QLF, ready, seminar, Solid, theory
Removed:
adenocarcinoma, Advisory, assessed, choose, collaborate, counsel, CRL, denying, ezutromid, Galenica, Goodwin, Hb, injection, irinotecan, joined, joining, Julian, Latin, liposome, LLP, Merrimack, modulator, ONIVYDE, Procter, Proctor, resubmitted, Stern, Summit, Tivorsan, Turkey, unexpected, utrophin
Valuein 2018 Q1 filing- Value in 2018 Q2 filing
Original filings
Filing view